This Article  • Full text  • PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on ISI (58)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Topic Collections  • Nutritional and Metabolic Disorders, Other  • Hypertension  • Alert me on articles by topic

Marvin Moser, MD

JAMA. 1998;279:1813-1816.

Diuretics have again been recommended by the Sixth Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure (JNC VI) as one of the first-choice medications in the management of hypertension. This recommendation is based on the results of numerous randomized, diuretic-based, long-term controlled clinical trials that have demonstrated a reduction in both cerebrovascular and cardiovascular morbidity. Despite this and other national recommendations, the use of diuretics has steadily decreased over the past 15 years. Reasons include heavy promotion of other medications and the perception that diuretics produce adverse metabolic effects and do not reduce coronary heart disease events. Data, however, indicate that (1) changes in glucose and cholesterol metabolism are minor, especially with the smaller doses now being used; (2) cardiovascular morbidity and mortality have been reduced in hypertensive patients, even in those with hyperlipidemia or diabetes, when diuretics are used; and (3) concerns about hypokalemia-induced arrhythmias have been overstated. While special indications exist for other medications in the treatment of hypertension, for example, use of an angiotensin-converting enzyme inhibitor (usually in addition to a diuretic) for a patient with heart failure or diabetic nephropathy, most patients, including those with hyperlipidemia or glucose intolerance, can be effectively treated with a diuretic as initial therapy or as part of a combination regimen. Diuretics should be used more not less frequently; use of diuretics would reduce the number of resistant hypertensive patients.

From the Yale University School of Medicine, New Haven, Conn.

THIS ARTICLE HAS BEEN CITED BY OTHER ARTICLES

Long-Term and Short-Term Changes in Antihypertensive Prescribing by Office-Based Physicians in the United States
Stafford et al.
Hypertension 2006;48:213-218.
ABSTRACT | FULL TEXT  

Have ALLHAT, ANBP2, ASCOT-BPLA, and So Forth Improved Our Knowledge About Better Hypertension Care?
Sawicki and McGauran
Hypertension 2006;48:1-7.
FULL TEXT  

Antihypertensive Medication Use Among US Adults With Hypertension
Gu et al.
Circulation 2006;113:213-221.
ABSTRACT | FULL TEXT  

Use of {beta}-Blockers and Risk of Fractures
Schlienger et al.
JAMA 2004;292:1326-1332.
ABSTRACT | FULL TEXT  

Update in Renal Transplantation
Magee and Pascual
Arch Intern Med 2004;164:1373-1388.
ABSTRACT | FULL TEXT  

Hydrochlorothiazide Versus Chlorthalidone: Evidence Supporting Their Interchangeability
Carter et al.
Hypertension 2004;43:4-9.
ABSTRACT | FULL TEXT  

Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure
Chobanian et al.
Hypertension 2003;42:1206-1252.
ABSTRACT | FULL TEXT  

Thiazide Diuretics and the Risk for Hip Fracture
Schoofs et al.
ANN INTERN MED 2003;139:476-482.
ABSTRACT | FULL TEXT  

Results of ALLHAT: Is This the Final Answer Regarding Initial Antihypertensive Drug Therapy?
Moser
Arch Intern Med 2003;163:1269-1273.
FULL TEXT  

Common Drug Pathways and Interactions
Kroner
Diabetes Spectr. 2002;15:249-255.
ABSTRACT | FULL TEXT  

Trends in Antihypertensive Drug Therapy by US Office-Based Physicians Response
Balas et al.
Hypertension 2001;37 :e12-e12.
FULL TEXT  

From the Clinics to the Courts: The Role Evidence Should Play in Litigating Medical Care
Morreim
Journal of Health Politics, Policy and Law 2001;26:409-428.
 

The Diffusion of a Novel Therapy Into Clinical Practice: The Case of Sildenafil
Harrold et al.
Arch Intern Med 2000;160:3401-3405.
ABSTRACT | FULL TEXT  

Admission Serum Potassium in Patients With Acute Myocardial Infarction : Its Correlates and Value as a Determinant of In-Hospital Outcome
Madias et al.
Chest 2000;118:904-913.
ABSTRACT | FULL TEXT  

Diuretics for Hypertension
Messerli et al.
JAMA 1999;282:523-525.
FULL TEXT  

National Recommendations for the Pharmacological Treatment of Hypertension: Should They Be Revised?
Moser
Arch Intern Med 1999;159:1403-1406.
FULL TEXT